Cross Shawn — SEC Form 4 filings
SEC reporting owner CIK 1734779. 11 Form 4 filings on record with FilingPulse; latest filed 2026-04-24.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-06-05 to 2026-04-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 7 legs across 4 filings — 62,060 shares, $1,521,351 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 21.
- Largest priced transaction: sale of 15,896 shares @ $25.03 ($397,877) in Pacira BioSciences, Inc., filed 2025-12-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Pacira BioSciences, Inc. (PCRX) | Chief Financial Officer | 7 | — | 7 legs · 62,060 sh · $1,521,351 | 16 |
| Cyclo Therapeutics, Inc. (CYTH) | Director | 4 | — | — | 5 |
Form 4 filings — Cross Shawn
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-04-24 | 4 | Pacira BioSciences, Inc. (PCRX) | Option exercise (M): 12,941 @ $16.45 · Sale (S): 12,941 @ $25.16 · Option exercise (M): 12,941 (derivative) @ $0 | EDGAR |
| 2026-04-22 | 4 | Pacira BioSciences, Inc. (PCRX) | Option exercise (M): 7,714 @ $16.45 · Sale (S): 7,714 @ $25.14 · Option exercise (M): 2,845 @ $16.45 · Sale (S): 2,845 @ $25.01 · Option exercise (M): 1,500 @ $16.45 · Sale (S): 1,500 @ $25.01 · +3 more | EDGAR |
| 2026-02-13 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 49,091 @ $0 | EDGAR |
| 2025-12-11 | 4 | Pacira BioSciences, Inc. (PCRX) | Option exercise (M): 15,896 @ $16.45 · Sale (S): 15,896 @ $25.03 · Option exercise (M): 9,104 @ $16.45 · Sale (S): 9,104 @ $25.14 · Option exercise (M): 15,896 (derivative) @ $0 · Option exercise (M): 9,104 (derivative) @ $0 | EDGAR |
| 2025-11-13 | 4 | Pacira BioSciences, Inc. (PCRX) | Sale (S): 12,060 @ $22.09 | EDGAR |
| 2025-11-03 | 4 | Pacira BioSciences, Inc. (PCRX) | Tax withholding (F): 6,690 @ $21.38 | EDGAR |
| 2025-03-03 | 4 | Cyclo Therapeutics, Inc. (CYTH) | Grant/award (A): 28,597 @ $0 | EDGAR |
| 2024-11-18 | 4 | Cyclo Therapeutics, Inc. (CYTH) | Grant/award (A): 17,228 @ $0 | EDGAR |
| 2024-11-05 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 75,000 @ $0 · Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2024-08-20 | 4 | Cyclo Therapeutics, Inc. (CYTH) | Grant/award (A): 9,028 @ $0 | EDGAR |
| 2024-06-05 | 4 | Cyclo Therapeutics, Inc. (CYTH) | Grant/award (A): 8,887 @ $0 · Grant/award (A): 15,562 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1734779 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →